AstraZeneca
AstraZeneca stock up despite pulling Covid-19 vaccine from European market
Business
09.05.2024
AstraZeneca stock up despite pulling Covid-19 vaccine from European market
Shares in AstraZeneca were slightly higher on Thursday despite an update on the European Medicines Agency’s website on Wednesday stating…
AstraZeneca requests European authorisation of Covid vaccine be pulled
World
08.05.2024
AstraZeneca requests European authorisation of Covid vaccine be pulled
The pharma giant AstraZeneca has requested that the European authorisation for its Covid-19 vaccine be pulled, according to the EU…
AstraZeneca отзывают свою вакцину против Covid-19
Мир
08.05.2024
AstraZeneca отзывают свою вакцину против Covid-19
AstraZeneca отзывает вакцину Covid-19 по всему миру. Официальная причина — падение спроса. Британский фармацевтический гигант AstraZeneca подтвердил в среду, что…
AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand
Business
25.04.2024
AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand
Pharmaceutical giant AstraZeneca reported its first quarter 2024 earnings on Thursday, seeing extremely robust earnings per share (EPS) and revenue…
AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand
Business
25.04.2024
AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand
Pharmaceutical giant AstraZeneca reported its first quarter 2024 earnings on Thursday, seeing extremely robust earnings per share (EPS) and revenue…
AstraZeneca CEO set to earn £18.7 million after shareholder backing
Business
13.04.2024
AstraZeneca CEO set to earn £18.7 million after shareholder backing
The chief executive of pharmaceutical giant AstraZeneca could earn up to £18.7 million (€21.9 million) this year after shareholders approved…
AstraZeneca shares tumble despite posting strong sales for cancer drug
Business
08.02.2024
AstraZeneca shares tumble despite posting strong sales for cancer drug
The Anglo-Swedish biopharmaceutical company reported $45.8bn (around €41.7bn) in revenue for the financial year 2023 and highlighted strong sales for its…
